Filter
1427
Text search:
drug
approval
Featured
Recommendations
95
New Publications
409
Language
Document type
No document type
838
Studies & Reports
258
Guidelines
180
Manuals
61
Strategic & Response Plan
40
Fact sheets
26
Training Material
15
Resource Platforms
4
Situation Updates
3
Brochures
1
Infographics
1
Countries / Regions
India
93
Global
47
Uganda
43
Kenya
42
Nigeria
37
South Africa
36
Malawi
34
Ethiopia
31
Nepal
28
Western and Central Europe
28
Myanmar / Burma
26
Tanzania
25
Sierra Leone
24
Liberia
23
Ghana
22
Zambia
22
Ukraine
22
Bangladesh
21
Rwanda
20
Namibia
19
Latin America and the Carribbean
18
Lesotho
16
Zimbabwe
14
Africa
14
South–East Asia Region
13
Eastern Europe
12
Botswana
11
Congo, Democratic Republic of
9
Burkina Faso
8
Philippines
8
Cambodia
8
Asia
8
Senegal
7
Thailand
6
Pakistan
5
Syria
5
China
5
Mozambique
5
Benin
5
Tajikistan
5
Russia
5
USA
4
Cameroon
4
South Sudan
4
Indonesia
4
Peru
4
East and Southern Africa
4
Albania
4
Germany
3
Eswatini/ Swaziland
3
West and Central Africa
3
Venezuela
3
Georgia
3
Vietnam
3
Somalia
2
Central African Republic
2
El Salvador
2
Mexico
2
Middle East and North Africa
2
Eastern Europe and Central Asia
2
Bhutan
2
Laos
2
Moldova
2
Jamaica
2
Guinea
1
Iraq
1
Afghanistan
1
Lebanon
1
Sudan
1
Argentina
1
Brazil
1
Colombia
1
Libya
1
Sri Lanka
1
Chile
1
Yemen
1
Western Pacific Region
1
Paraguay
1
Fiji
1
Palestine
1
Armenia
1
Qatar
1
Iran
1
Uzbekistan
1
Kyrgyzstan
1
Australia
1
Kazakhstan
1
North America
1
Turkmenistan
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
629
Clinical Guidelines
118
Public Health
41
Key Resources
38
Women & Child Health
35
Pharmacy & Technologies
33
Capacity Building
13
Toolboxes
HIV
176
TB
134
AMR
102
Mental Health
72
COVID-19
72
Pharmacy
64
NTDs
54
Ebola & Marburg
25
NCDs
24
Rapid Response
22
Caregiver
21
Health Financing Toolbox
17
Planetary Health
16
Malaria
15
Global Health Education
12
Conflict
11
Refugee
11
2.0 Rapid Response
10
Disability
9
Zika
7
Polio
5
Natural Hazards
4
Specific Hazards
4
Cholera
1
Social Ethics
1
A case study from Albania
June 2016
EHRN is grateful to all who contributed to this document, especially (in alphabetical order): Alena Alba, Program Officer, Eastern Europe and Central Asia Team, Asia, Europe, Latin America and the Caribbean Department, The Global Fund to Fight AIDS, Tuberc
...
The Antimicrobial Resistance Benchmark has evaluated for the second time how the most important players in the antibiotic market are addressing the rise of resistance and the global need for appropriate access to antibiotics. Although we can see progress — it’s hanging by a thread.
We have reac
...
Evidence for improving community health supply chains from Ethiopia, Malawi and Rwanda. Journal of Global Health vol. 4 No.2 (2014)
WHO GUIDELINES REVIEW COMMITTEE
This document describes the key areas that national governments should consider for the introduction and scale-up of point-of-care (POC) diagnostics within national programmes, as new innovative POC technologies are being introduced into the market. The next steps taken to include these new innovati
...
Submitted to the US Agency for International Development by the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program.
Global actions to reduce antimicrobial resistance (AMR) include optimising the use of antimicrobial medicines in human and animal health. In countries with weak healthcare regulation, this requires a greater understanding of the drivers of antibiotic use from the perspective of providers and consume
...
Antimicrobial resistance (AMR) is a serious public health concern with economic, social and political implications that are global in scope, and cross all environmental and ethnic boundaries. As a global threat, AMR risks the achievements of modern medicine, and has the po
...
Methicillin-resistant Staphylococcus aureus(MRSA) strainsor multidrug-resistant S.aureus, initially described in 1960s,emerged in the last decade as a cause of nosocomial infections responsible for rapidly progressive, potential fatal diseases including life-threatening pneumonia, necrotizing fascii
...
The National Tuberculosis Programme (NTP) of Rwanda (known as TB & ORD Division/IHDPC/RBC) is preparing to write their next National Strategic Plan and for this reason Rwanda was selected as a country to received technical assistance (TA) to conduct an assessment of their surveillance system using t
...
Sierra Leone Trial to Introduce a Vaccine against Ebola (STRIVE)
The Global Campaign Against Epilepsy “Out of the Shadows”
Bull World Health Organ 2017;95:594–598
Recent systematic reviews and meta-analysis of the impact of chemical-based mollusciciding (King et al., 2015, Sokolow et al., 2016) have concluded that regular mollusciciding is likely to contribute significantly towards elimination of schistosomiasis in high-risk areas. The WHO roadmap’s new foc
...
A case study from Bosnia and Herzegovina Eurasian Harm Reduction Network
The case study was prepared by Samir Ibisevic, President of PROI between March and June 2016 and edited by Graham Shaw.
EHRN is grateful to all who contributed to this document, especially: Dr. Serifa Godinjak, Chairperson
...
Time has seen management for Cystic Fibrosis (CF) advance drastically, most recently in the development of the disease-modifying triple combination therapy ivacaftor/tezacaftor/elexacaftor. There is currently limited evidence regarding both the global epidemiology of CF and access to this transforma
...
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i
...
